Wolfe starts IFF at Underperform, says valuation in line with higher-end product

Wolfe Research initiated coverage of IFF with an Underperform rating and $66 price target. The firm said that IFF’s valuation is more in line with its higher-end products rather than its lower-growth products, but the firm suspects this will evolve over time, especially in the event of another asset sale.